Ping An Healthcare and Technology Company (1833) AI Stock Analysis

• Market Cap: HK$25.72B
• Dividend Yield: N/A
• Average Volume (3M): 17.30M
• Price to Earnings (P/E): 29.6
• Beta (1Y): 1.25
• Revenue Growth: 14.56%
• EPS Growth: N/A
• Country: HK
• Employees: 1,563
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 2,161,443,600
• 10 Day Avg. Volume: 8,945,339
• 30 Day Avg. Volume: 17,297,252
• PEG Ratio: -0.66
• Price to Book (P/B): 1.86
• Price to Sales (P/S): 1.39
• P/FCF Ratio: 102.34
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$18.83
• Price Target Upside: 9.77% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): 0.18
• Revenue Forecast (FY): HK$6.25B

• Rating: 45 Neutral
• Price Target: HK$16.00 ▼(-6.71% Downside)
• Action: Reiterated Date: 10/29/25
• Date: Action: Reiterated 10/29/25

The overall stock score is primarily influenced by mixed financial performance and bearish technical indicators. While the company has strong cash reserves and a high dividend yield, the high P/E ratio and negative market momentum present significant risks. The lack of earnings call data and corporate events further limits positive influences on the score.

Positive Factors

Strong cash reserves and low leverage

Substantial cash and low leverage provide durable financial flexibility, allowing the company to fund technology, regulatory compliance, and platform expansion without immediate reliance on external financing. This buffer supports multi‑quarter strategic execution through downturns.

Improving operating cash flow

A shift to positive operating cash flow signals improving core cash generation from services. Over the medium term this enhances self‑funding capacity for product development and sales investments, reducing funding risk if the trend proves persistent rather than episodic.

Platform tied to Ping An ecosystem

Integration with the Ping An ecosystem provides durable distribution advantages, cross‑sell opportunities and large enterprise channels. These network and referral effects can sustain user acquisition economics and support scale in healthcare services over multiple quarters.

Negative Factors

Historically negative EBIT and EBITDA margins

Persistent negative operating margins undermine ability to convert revenue into sustainable profits. Without sustained margin recovery, the business will struggle to fund growth internally and demonstrate durable economics to investors, raising medium‑term viability concerns.

Inconsistent free cash flow

Volatile free cash flow limits predictable reinvestment in product, sales, and regulatory compliance. Even with improved operating cash flow, inconsistent FCF increases likelihood of needing external capital or cutting strategic spends, hindering steady long‑term execution.

Weak return on equity from volatile net income

A weak ROE driven by earnings volatility signals inefficient capital use and uncertain profit generation. Over the medium term this can erode investor confidence and limit access to low‑cost capital, constraining expansion unless operational consistency improves.

Ping An Healthcare and Technology Company Business Overview & Revenue Model

Company Description

Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in the People's Republic of China. It offers online medical services, such as online consultation, hospital referral and appointment, inpatient arrangement, and second opinion services; and consumer healthcare services, including various standardized service packages that integrate services at healthcare institutions. The company also provides healthcare products comprising medicines, health supplements, and medical devices; wellness products comprising fitness equipment and accessories, and personal care products; and other products. In addition, it offers health management and wellness interaction services, such as wellness programs, tools and activities, and personalized content. Further, the company provides medicine marketing services; technology services; application development and operation services; and hospital and clinic services, as well as operates an insurance agency. Ping An Healthcare and Technology Company Limited was incorporated in 2014 and is headquartered in Shanghai, China.

How the Company Makes Money

Ping An Healthcare and Technology generates revenue through multiple streams. Its primary revenue comes from online healthcare services, including telemedicine consultations and health management solutions, which attract a wide user base due to their convenience and accessibility. The company also earns income from partnerships with hospitals and healthcare providers, enabling a comprehensive service network. Additionally, it offers insurance services, which contribute to its financial performance. Strategic collaborations with technology firms enhance its service offerings and expand its market reach, further solidifying its revenue model.

Ping An Healthcare and Technology Company Financial Statement Overview

Summary

Ping An Healthcare and Technology Company displays mixed financial health. While there are positive signs in cash reserves and recent profitability improvements, the company faces challenges with maintaining consistent revenue growth and profitability. The balance sheet remains robust with low leverage, but operational efficiency needs to be enhanced to support sustainable growth.

Income Statement

The company shows a concerning trend in profitability with negative EBIT and EBITDA margins over the years. However, there is a recent improvement in net income, indicating potential recovery. The gross profit margin remains healthy, but revenue growth has been volatile, signaling uncertainty in financial performance.

Balance Sheet

The company maintains strong cash reserves as indicated by the substantial cash and short-term investments. The debt-to-equity ratio is low, suggesting conservative use of leverage. However, the return on equity is weak due to inconsistent net income, which could be a potential risk if profitability does not stabilize.

Cash Flow

There is a positive shift in operating cash flow, moving from negative to positive, suggesting improvement in cash generation. However, free cash flow remains inconsistent, which could impact future investments. The free cash flow to net income ratio shows improvement, but overall cash flow stability needs attention.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.22B	4.81B	4.67B	6.21B	7.33B	6.87B
Gross Profit	1.69B	1.52B	1.51B	1.67B	1.71B	1.86B
EBITDA	332.77M	193.43M	-164.23M	-1.05B	-1.76B	-605.20M
Net Income	158.94M	81.43M	-322.59M	-636.06M	-1.54B	-948.48M
Balance Sheet
Total Assets	12.95B	16.78B	16.52B	17.14B	17.88B	18.56B
Cash, Cash Equivalents and Short-Term Investments	7.76B	11.52B	11.35B	10.14B	10.14B	13.53B
Total Debt	45.97M	45.00M	93.61M	176.49M	201.29M	113.97M
Total Liabilities	3.26B	13.20B	3.25B	3.68B	3.79B	2.71B
Stockholders Equity	9.70B	3.59B	13.28B	13.46B	14.08B	15.83B
Cash Flow
Free Cash Flow	270.60M	65.08M	-325.82M	-845.05M	-1.49B	-1.18B
Operating Cash Flow	297.89M	99.33M	-282.86M	-810.62M	-1.40B	-1.10B
Investing Cash Flow	3.49B	114.65M	-1.49B	1.71B	-3.10B	-2.50B
Financing Cash Flow	-3.94B	-38.44M	-67.36M	-317.88M	-319.91M	6.92B

Ping An Healthcare and Technology Company Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 17.15
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Negative. The current price of 17.15 is above the 20-day moving average (MA) of 13.32, above the 50-day MA of 14.69, and above the 200-day MA of 13.89, indicating a bearish trend. The MACD of -0.78 indicates Positive momentum. The RSI at 26.16 is Positive, neither overbought nor oversold. The STOCH value of 10.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1833.

Ping An Healthcare and Technology Company Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2276	72 Outperform	HK$29.60B	14.57	24.01%	0.63%	13.58%	24.59%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
2159	47 Neutral	HK$417.20M	-6.27	-35.99%	―	-5.38%	63.93%
1833	45 Neutral	HK$25.72B	29.64	1.37%	―	14.56%	―
1952	45 Neutral	HK$12.59B	-36.96	-15.75%	―	102.73%	38.42%
2158	45 Neutral	HK$6.19B	-110.24	-2.28%	―	-4.99%	47.18%
2251	40 Neutral	HK$1.18B	-176.64	-13.92%	―	-32.17%	-1.20%